Literature DB >> 16280032

Effect of exercise on ovarian morphology and expression of nerve growth factor and alpha(1)- and beta(2)-adrenergic receptors in rats with steroid-induced polycystic ovaries.

L Manni1, S Cajander, T Lundeberg, A S Naylor, L Aloe, A Holmäng, I H Jonsdottir, E Stener-Victorin.   

Abstract

Oestadiol valerate (EV)-induced polycystic ovaries (PCO) in rats cause anovulation and cystic ovarian morphology. Denervation of ovarian sympathetic nerves restores ovulatory disruption. In the present study, we determined whether 5 weeks of voluntary exercise influence ovarian morphology and the expression of sympathetic markers in the EV-induced PCO rat model. The effect of exercise on (i) ovarian morphology; (ii) mRNA and protein expression of nerve growth factor (NGF); and (iii) mRNA and number of ovarian-expressing cells for the NGF receptor (p75 neurotrophin receptor) and the alpha(1a)-, alpha(1b)-, alpha(1d)- and beta(2)-adrenergic receptors (ARs) in rats with EV-induced PCO was evaluated. PCO was induced by a single i.m. injection of EV, and controls were injected with oil alone in adult cycling rats. The rats were divided into four groups: (i) control (oil); (ii) exercise group (oil + exercise); (iii) a PCO group (EV); and (iv) a PCO exercise group (EV + exercise). The exercise and PCO exercise groups ran voluntarily for 5 weeks in computer-monitored wheels placed in the cages where they were housed. The results obtained indicated that ovarian morphology was almost normalised in the PCO exercise group; NGF mRNA and protein concentrations were normalised in the PCO exercise group; high numbers of NGF receptor expressing cells in PCO ovaries were lowered by exercise; and the number of immunopositive cells of the different AR subtypes were all reduced after exercise in the PCO group, except for the alpha(1b)- and beta(2)-AR whereas the mRNA levels were unaffected, indicating transcriptional regulation. In conclusion, our data indicate a beneficial effect of regular exercise, as a modulator of ovarian sympathetic innervation, in the prevention and treatment of human PCOS.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16280032     DOI: 10.1111/j.1365-2826.2005.01378.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  12 in total

Review 1.  Acupuncture in clinical and experimental reproductive medicine: a review.

Authors:  G Franconi; L Manni; L Aloe; F Mazzilli; G Giambalvo Dal Ben; A Lenzi; A Fabbri
Journal:  J Endocrinol Invest       Date:  2011-02-04       Impact factor: 4.256

Review 2.  Oligomenorrhoea in exercising women: a polycystic ovarian syndrome phenotype or distinct entity?

Authors:  Susan Awdishu; Nancy I Williams; Sheila E Laredo; Mary Jane De Souza
Journal:  Sports Med       Date:  2009       Impact factor: 11.136

3.  Trace glucose and lipid metabolism in high androgen and high-fat diet induced polycystic ovary syndrome rats.

Authors:  Hua-Ling Zhai; Hui Wu; Hui Xu; Pan Weng; Fang-Zhen Xia; Yi Chen; Ying-Li Lu
Journal:  Reprod Biol Endocrinol       Date:  2012-01-25       Impact factor: 5.211

4.  Hyberbaric oxygen increases atresia in normal & steroid induced PCO rat ovaries.

Authors:  Alev Atis; Yavuz Aydin; Filiz Ciftci; Damlanur Sakız; Abdullah Arslan; Akın S Toklu; Melahat Donmez; Nimet Goker
Journal:  Reprod Biol Endocrinol       Date:  2012-02-06       Impact factor: 5.211

5.  The celiac ganglion modulates LH-induced inhibition of androstenedione release in late pregnant rat ovaries.

Authors:  Marilina Casais; Silvia M Delgado; Zulema Sosa; Carlos M Telleria; Ana M Rastrilla
Journal:  Reprod Biol Endocrinol       Date:  2006-12-21       Impact factor: 5.211

6.  The characterization of obese polycystic ovary syndrome rat model suitable for exercise intervention.

Authors:  Chuyan Wu; Feng Lin; Shuwei Qiu; Zhongli Jiang
Journal:  PLoS One       Date:  2014-06-06       Impact factor: 3.240

7.  Expression of the beta-2 adrenergic receptor (ADRB-2) in human and monkey ovarian follicles: a marker of growing follicles?

Authors:  Christoph Merz; Sabine Saller; Lars Kunz; Jing Xu; Richard R Yeoman; Alison Y Ting; Maralee S Lawson; Richard L Stouffer; Jon D Hennebold; Francis Pau; Gregory A Dissen; Sergio R Ojeda; Mary B Zelinski; Artur Mayerhofer
Journal:  J Ovarian Res       Date:  2015-03-07       Impact factor: 4.234

Review 8.  Complementary therapy in polycystic ovary syndrome.

Authors:  C I Aquino; S L Nori
Journal:  Transl Med UniSa       Date:  2014-04-24

9.  Impact of different omega-3 fatty acid sources on lipid, hormonal, blood glucose, weight gain and histopathological damages profile in PCOS rat model.

Authors:  Fiza Komal; Muhammad Kamran Khan; Muhammad Imran; Muhammad Haseeb Ahmad; Haseeb Anwar; Usman Ali Ashfaq; Nazir Ahmad; Amna Masroor; Rabia Shabir Ahmad; Muhammad Nadeem; Mahr Un Nisa
Journal:  J Transl Med       Date:  2020-09-14       Impact factor: 5.531

10.  In rats with estradiol valerate-induced polycystic ovary syndrome, the acute blockade of ovarian β-adrenoreceptors improve ovulation.

Authors:  Berenice Venegas; Lizzbeth Yureli De León Gordillo; Gabriela Rosas; Julieta A Espinoza; Carolina Morán; Roberto Domínguez; Leticia Morales-Ledesma
Journal:  Reprod Biol Endocrinol       Date:  2019-11-19       Impact factor: 5.211

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.